Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES)
G Bosco, San Ospedale, Luca Altamura, Andrés Ferrara, Monica Beraldi, Corrado Vassanelli(University of Verona), J. Pellanda, M. Anselmi, Carlo Zivelonghi(Ziekenhuisnetwerk Antwerpen Stuivenberg), Giovanni De Persio, Leonardo De Luca(Mount Sinai Hospital), Giovanni Luca(University of Perugia), Olga Skossyreva, D. Spartà, Radwan Abukarsh, Cristina Aurigemma(Università Cattolica del Sacro Cuore), Francesca Pastori, S. Dal Dosso, Alessandro Petrolini, F. Tomai. Ospedale, J.-F. Tanguay(Montreal Heart Institute)
Cited by 29
Related Papers
Navigating the Crossroads of Coronary Artery Disease and Heart Failure
|Circulation|2006|405
Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes
|Diabetes Care|2006|321
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials
|European Heart Journal|2008|258